未知生产厂商
NPS-2143 is the prototype calcilytic drug, designed to act on calcium receptors on the surface of parathyroid glands, stimulating the release of the body's own stores of native parathyroid hormone (PTH).
Investigated for use/treatment in osteoporosis.
每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。
